Development of a Broad-Spectrum High Affinity Antibody for a Non-Targeted Early Warning and Verification Strategy of Organophosphorus Nerve Agents Exposure

Phosphonyl tyrosine is one of the main biomarkers to confirm exposure to highly lethal organophosphorus nerve agents (OPNAs) in vivo. However, a critical challenge remains unresolved: ionization suppression occurs during the analysis of phosphonyl tyrosine by high-resolution mass spectrometry (HRMS) or tandem mass spectrometry (MS/MS), which is induced by the high concentrations of free amino acids present in the digestion solution. In this study, based on the broad-spectrum immunomagnetic beads with high affinity antibodies, a non-targeted early warning and verification strategy was developed. Compared with the recommended operating procedures for analysis in the verification of chemical disarmament, the total analysis time was reduced from several hours to about 30 min. Moreover, the detection sensitivity was increased by nearly one order of magnitude, and the detection limit (LOD) was 0.01 ng/mL. Furthermore, the screening strategy can cover all OPNAs listed as 1A.01, 1A.02 and 1A.03 in Schedule 1 of the CWC. Therefore, we have developed a rapid, sensitive, and broad-spectrum approach to accurately screen for OPNAs exposure, while also offering a novel strategy and technical support for chemical defense and occupational health assessment.